Live News Categoriesmarket

FEMY.O (FEMY.O) News

Follow FEMY.O (FEMY.O) news in one place: company catalysts, earnings, analyst actions and wider market developments. Review 1 public stories across 1 publication days to understand how the story developed. Public news appears after a 15-minute delay; LiveCast subscribers can follow new headlines and hear important updates without this additional delay.

Symbol FEMY.O Asset market Sector Markets 90 days 1 Updated Oct 14, 2026, 01:04 PM UTC Open live news feed

L Femasys doubles enrolling sites to 12 in FemBloc FINALE pivotal trial for permanent birth control Femasys doubled actively enrolling U.S. sites to 12 for its FemBloc FINALE pivotal trial in non-surgical permanent birth control. No trial results were presented; the expanded enrollment is intended to support completion REGULATION | Oct 14, 2026, 01:04 PM UTC